Microarray expression profile analysis of long non-coding RNAs in human gastric cardiac adenocarcinoma

Cellular Physiology and Biochemistry

Volumn 33, Issue 4, 2014, Pages 1225-1238

  Wang, Ying ^a   Gao, Shegan ^a   Liu, Gang ^a   Jia, Ruinuo ^a   Fan, Daiming ^b   Feng, Xiaoshan ^a  

^a HENAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Carcinogenesis; Gastric cardiac adenocarcinoma; lncRNA; Microarray

Indexed keywords

LONG UNTRANSLATED RNA; MESSENGER RNA; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; BIOINFORMATICS; CARCINOGENESIS; CLINICAL ARTICLE; DOWN REGULATION; FEMALE; GASTRIC CARDIAC ADENOCARCINOMA; HOMEOSTASIS; HUMAN; HUMAN TISSUE; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; ONTOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; STOMACH ADENOCARCINOMA; UPREGULATION; CANCER TISSUE; CARDIA CARCINOMA; CONTROLLED STUDY; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE ONTOLOGY; GENE REGULATORY NETWORK; QUANTITATIVE ANALYSIS; RNA HYBRIDIZATION; ADENOCARCINOMA; BIOLOGY; GENETICS; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; STOMACH TUMOR;

ADENOCARCINOMA; ADULT; AGED; BIOLOGICAL MARKERS; COMPUTATIONAL BIOLOGY; DOWN-REGULATION; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; RNA, LONG NONCODING; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; UP-REGULATION;

EID: 84898671963     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000358692     Document Type: Article

References (46)

1. Vaughan TL, Davis S, Kristal A, Thomas DB: Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma. Cancer Epidem Biomar 1995;4:85-92.
2. Xin S, Lidong W, Zhiwei C, Fubao C, Zhong L, Xuemin L, Ran W, Zongmin F, Xin H, Zhiguo C: Distribution of ABO Blood Groups in High and Low Incidence Areas for Gastric Cardia Adenocarcinoma [J]. J. Basic Clin Oncol 2008;3:002.
3. Mattick JS, Makunin IV: Non-coding RNA. Hum Mo Gen 2006;15:R17-R29.
4. Eddy SR: Non-coding RNA genes and the modern RNA world. Nat Rev Genet 2001;2:919-929.
5. Griffiths-Jones S, Moxon S, Marshall M, Khanna A, Eddy SR, Bate man A: Rfam: annotating non-coding RNAs incomplete genomes. Nucleic Acids Res 2005;33:D121-D124.
6. Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ, Tsai M-C, Hung T, Argani P, Rinn JL: Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010;464:1071-1076.
7. Mercer TR, Dinger ME, Mattick JS: Long non-coding RNAs: insights into functions. Nat Rev Genet 2009;10:155-159.
8. Ponting CP, Oliver PL, Reik W: Evolution and functions of long noncoding RNAs. Cell 2009;136:629-641.
9. Moran VA, Perera RJ, Khalil AM: Emerging functional and mechanistic paradigms of mammalian long non-coding RNAs. Nucleic Acids Res 2012;40:6391-6400.
10. Augoff K, McCue B, Plow EF, Sossey-Alaoui K: miR-31 and its host gene IncRNA LOC554202 are regulated by promoter hypermethylation in triple-negative breast cancer. Mol Cancer 2012;11:5.
11. Zhang B, Arun G, Mao YS, Lazar Z, Hung G, Bhattacharjee G, Xiao X, Booth CJ, Wu J, Zhang C: The IncRNA Malatl Is Dispensable for Mouse Development but Its Transcription Plays a cis-Regulatory Role in the Adult. Cell Rep 2012;2:111-123.
12. Hung X Chang HY: Long noncoding RNA in genome regulation: prospects and mechanisms. RNA Biol 2010;7:582-585.
13. Wang KC, Chang HY: Molecular mechanisms of long noncoding RNAs. Mol Cell 2011;43:904-914.
14. Wapinski J, Chang HY: Long noncoding RNAs and human disease. Trends Cell Biol 2011;21:354-361.
15. Nagano X Fraser P: No-nonsense functions for long noncoding RNAs. Cell 2011;145:178-181.
16. Rinn JL, Chang HY: Genome regulation by long noncoding RNAs. Annual RevBiochem 2012;81:145-166.
17. Lai M-c, Yang Z, Zhou L, Zhu Q-q, Xie H-y, Zhang F, Wu L-m, Chen L-m, Zheng S-s: Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation. Med Oncol 2012;29:1810-1816.
18. Braconi C, Kogure X Valeri N, Huang N, Nuovo G, Costinean S, Negrini M, Miotto E, Croce C, Patel T: microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer. Oncogene 2011;30:4750-4756.
19. Han L, Zhang K, Shi Z, Zhang J, Zhu J, Zhu S, Zhang A, Jia Z, Wang G, Yu S: LncRNA profile of glioblastoma reveals the potential role of IncRNAs in contributing to glioblastoma pathogenesis. Int J Oncol 2012;40:2004.
20. Johnson SC: Hierarchical clustering schemes. Psychometrika 1967;32:241-254.
21. Fukayama M, Hayashi Y, Iwasaki Y, Chong J, Ooba X Takizawa X Koike M, Mizutani S, Miyaki M, Hirai K: Epstein-Barr virus-associated gastric carcinoma and Epstein-Barr virus infection of the stomach. Lab Invest 1994;71:73-81.
22. Shibata D, Tokunaga M, Uemura Y, Sato E, Tanaka S, Weiss L: Association of Epstein-Barr virus with undifferentiated gastric carcinomas with intense lymphoid infiltration. Lymphoepithelioma-like carcinoma. AmJPatholl991;139:469.
23. Oda K, Tamaru J, Takenouchi X Mikata A, Nunomura M, Saitoh N, Sarashina H, Nakajima N: Association of Epstein-Barr virus with gastric carcinoma with lymphoid stroma. Am J Pathol 1993;143:1063.
24. Johansson K, Ask P, Boeryd B, Fransson S, Tibbling L: Oesophagitis, signs of reflux, and gastric acid secretion in patients with symptoms of gastro-oesophageal reflux disease. Scand J Gastroentero 1986;21:837-847.
25. Mearin F, Mourelle M, Guarner F, Salas A, Rtveros-Moreno V, Moncada S, Malagelada JR: Patients with achalasia lack nitric oxide synthase in the gastro-oesophageal junction. Eur J Clin Invest 1993;23:724-728.
26. Ratnasinghe LD, Abnet C, Qiao Y-L, Modali R, Stolzenberg-Solomon R, Dong Z-W, Dawsey SM, Mark SD, Taylor PR: Polymorphisms of XRCC1 and risk of esophageal and gastric cardia cancer. Cancer Lett 2004;216:157-164.
27. Gibb EA, Brown CJ, Lam WL: The functional role of long non-coding RNA in human carcinomas. Mol Cancer 2011;10:38-55.
28. Zhang J, Jin X, Fang S, Wang R, Li Y, Wang N, Guo W, Wang Y, Wen D, Wei L: The functional polymorphism in the matrix metalloproteinase-7 promoter increases susceptibility to esophageal squamous cell carcinoma, gastric cardiac adenocarcinoma and non-small cell lung carcinoma. Carcinogenesis 2005;26:1748-1753.
29. Zhang J, Jin X, Fang S, Li Y, Wang R, Guo W, Wang N, Wang Y, Wen D, Wei L: The functional SNP in the matrix metalloproteinase-3 promoter modifies susceptibility and lymphatic metastasis in esophageal squamous cell carcinoma but not in gastric cardiac adenocarcinoma. Carcinogenesis 2004;25:2519-2524.
30. Yan L, Yanan D, Donglan S, Na W, Rongmiao Z, Zhifeng C: Polymorphisms of XRCC1 gene and risk of gastric cardiac adenocarcinoma. Dis Esophagus 2009;22:396-401.
31. Zhou RM, Wang N, Chen ZF, Duan YN, Sun DL, Li Y: Polymorphisms in promoter region of FAS and FASL gene and risk of gastric cardiac adenocarcinoma. J Gastroentero Hepat 2010;25:555-561.
32. Zhou R, Li Y, Wang N, Zhang X, Dong X, Guo W: Correlation of XPC Ala499Val and Lys939Gln polymorphisms to risks of esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma]. Chin J Cancer 2006;25:1113.
33. Zhang J, Cui Y, Kuang G, Li Y, Wang N, Wang R, Guo W, Wen D, Wei L, Yu F: Association of the thymidylate synthase polymorphisms with esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma. Carcinogenesis 2004;25:2479-2485.
34. Guo W Wang N, Li Y, Zhang J-H: Polymorphisms in tumor necrosis factor genes and susceptibility to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma in a population of high incidence region of North China. Chinese Med J 2005;118:1870-1878.
35. Miao X, Yu C, Tan W, Xiong P, Liang G, Lu W, Lin D: A functional polymorphism in the matrix metalloproteinase-2 gene promoter (-1306C/T) is associated with risk of development but not metastasis of gastric cardia adenocarcinoma. Cancer Res 2003;63:3987-3990.
36. Yu C-D, Xu S-H, Mou H-Z, Jiang Z-M, Zhu C-H, Liu X-L: Gene expression profile differences in gastric cancer, pericancerous epithelium and normal gastric mucosa by gene chip. World J Gastroenterol 2005;11:2390-12397.
37. Jâcome AAA, Wohnrath DR, Neto CS, Carneseca EC, Serrano SV, Viana LS, Nunes JS, Martinez EZ, Santos JS: Prognostic value of epidermal growth factor receptors in gastric cancer: a survival analysis by Weibull model incorporating long-term survivors. Gastric Cancer 2014;17:76-86.
38. Huseman B: Cardia carcinoma considered as a distinct clinical entity. Brit J Surg 1989;76:136-139.
39. van Baal JW, Milano F, Rygiel AM, Bergman JJ, Rosmolen WD, van Deventer SJ, Wang KK, Peppelenbosch MP, Krishnadath KK: A comparative analysis by SAGE of gene expression profiles of Barretts esophagus, normal squamous esophagus, and gastric cardia. Gastroentero 2005;129:1274-1281.
40. Zambon A, Mandruzzato S, Parenti A, Macino B, Dalerba P, Ruol A, Merigliano S, Zaninotto G, Zanovello P: MAGE, BAGE, and GAGE gene expression in patients with esophageal squamous cell carcinoma and adenocarcinoma of the gastric cardia. Cancer 2001;91:1882-1888.
41. Yang F, Zhang L, Huo Xs, Yuan Jh, Xu D, Yuan Sx, Zhu N, Zhou Wp, Yang Gs, Wang Yz: Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans. Hepatology 2011;54:1679-1689.
42. Orom UA, Derrien T, Beringer M, Gumireddy K, Gardini A, Bussotti G, Lai F, Zytnicki M, Notredame C, Huang Q: Long noncoding RNAs with enhancer-like function in human cells. Cell 2010;143:46-58.
43. Arents G, Burlingame RW, Wang B-C, Love WE, Moudrianakis EN: The nucleosomal core histone octamer at 3.1 A resolution: a tripartite protein assembly and a left-handed superhelix. Proc Natl Acad Sei USA 1991;88:10148-10152.
44. Sleumer MC, Wei G, Wang Y, Chang H, Xu T, Chen R, Zhang MQ: Regulatory elements of Caenorhabditis elegans ribosomal protein genes. BMC Genomics 2012;13:433.
45. Tseng S-F, Chang C-Y, Wu K-J, Teng S-C: Importin KPNA2 is required for proper nuclear localization and multiple functions of NBS1. J Biol Chem 2005;280:39594-39600.
46. Purtilo D: Epstein-Barr-virus-induced oncogenesis in immune-deficient individuals. Lancet 1980;315:300-303.